Cargando…
Antifungal Combinations against Candida Species: From Bench to Bedside
Candida spp. is the major causative agent of fungal infections in hospitalized patients and the fourth most common cause of nosocomial bloodstream infection (BSI). The availability of standardized methods for testing the in vitro activity of antifungals along with the expanding of antifungal armamen...
Autores principales: | Fioriti, Simona, Brescini, Lucia, Pallotta, Francesco, Canovari, Benedetta, Morroni, Gianluca, Barchiesi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605143/ https://www.ncbi.nlm.nih.gov/pubmed/36294642 http://dx.doi.org/10.3390/jof8101077 |
Ejemplares similares
-
Antifungal Combinations in Dermatophytes
por: Brescini, Lucia, et al.
Publicado: (2021) -
In Vitro Activity of Novel Lipopeptides against Triazole-Resistant Aspergillus fumigatus
por: Fioriti, Simona, et al.
Publicado: (2022) -
The Clinical Characteristics of Bloodstream Infections Due to Candida spp. in Patients Hospitalized in Intensive Care Units during the SARS-CoV-2 Pandemic: The Results of a Multicenter Study
por: Pallotta, Francesco, et al.
Publicado: (2023) -
Candidemia in Internal Medicine: Facing the New Challenge
por: Brescini, Lucia, et al.
Publicado: (2022) -
Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
por: Tortorano, Anna Maria, et al.
Publicado: (2021)